Symposium 12 (open)
Depression and Ketamine

Thursday, October 24, 2013: 8:30 AM-11:30 AM
Chairs:
Discussant:
 
12.1
Efficacy of Intravenous Ketamine Administration for Treatment-Resistant Major Depression and Posttraumatic Stress Disorder
Adriana Feder, MD Icahn School of Medicine at Mount Sinai, New York, NY
 
12.2
Prevalence and Predictors of Non-Response to Treatment in Adolescent Major Depressive Disorder
David A. Brent, MD Western Psychiatric Institute & Clinic, Pittsburgh, PA
 
12.3
Intranasal Ketamine in Depression
Kyle Lapidus, MD, PhD Icahn School of Medicine at Mount Sinai, New York, NY
 
12.4
Ketamine Therapy and Possible Implications for Adolescent Treatment-Resistant Depression
Vilma Gabbay, M.D., M.S. Mount Sinai School of Medicine, New York, NY

See more of: Symposium
Copyright ©2013 - American Academy of Child Adolescent Psychiatry. All Rights Reserved.